Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin's lymphoma: a phase II, non-randomized controlled trial.

Jessica HochbergJaclyn BassoQiuhu ShiLiana KlejmontAllyson FlowerKristina BortfeldLauren HarrisonCarmella van de VenChitti MoorthyHumayun IslamPerry GerardStephan VossMitchell S Cairo

Published in: Journal for immunotherapy of cancer (2022)

NCT02398240.

Keyphrases

hodgkin lymphoma
phase ii
newly diagnosed
young adults
randomized controlled trial
clinical trial
open label
study protocol
diffuse large b cell lymphoma
physical activity
phase iii
placebo controlled
double blind
systematic review